{"type":"rich","version":"1.0","title":"Under the Radar: Southeast Asia’s first and only precision gut microbiome company AMILI on business verticals of microbiome sequencing and intervention; Global digestive health market to reach US$104b by 2032; Expanding research scope to look at patients undergoing cancer therapy; Funding from East Ventures; Expansion into Indonesia","author_name":"Money Matters with Hongbin Jeong and Chua Tian Tian (4pm - 7pm)","author_url":"https://www.moneyfm893.sg/shows/the-evening-runway-with-hongbin-jeong-roshan-gidwani-chua-tian-tian/","provider_name":"Omny Studio","provider_url":"https://omny.fm","html":"<iframe src=\"https://omny.fm/shows/moneyfm-evening-show/under-the-radar-southeast-asia-s-first-and-only-pr/embed\" width=\"100%\" height=\"180\" allow=\"autoplay; clipboard-write; fullscreen\" allowfullscreen frameborder=\"0\" title=\"Under the Radar: Southeast Asia’s first and only precision gut microbiome company AMILI on business verticals of microbiome sequencing and intervention; Global digestive health market to reach US$104b by 2032; Expanding research scope to look at patients undergoing cancer therapy; Funding from East Ventures; Expansion into Indonesia\"></iframe>","width":600,"height":180}